GMFH Highlights from the Collège de France Symposium
Dr. Philippe Sansonetti, current chair of microbiology and infectious diseases at Collège de France, hosted a Microbiome and Nutrition symposium in June, 2014. At the event, esteemed researchers exchanged ideas and presented microbiome research from all over the world. As
Dr. Philippe Sansonetti, current chair of microbiology and infectious diseases at Collège de France, hosted a Microbiome and Nutrition symposium in June, 2014. At the event, esteemed researchers exchanged ideas and presented microbiome research from all over the world.
As one speaker described the symposium, “[It] was organized with the idea in mind to gather experts in the area of microbiome, nutrition and metabolism to give open lectures which are free to the public. The speakers also got to interact together through lunches and a dinner, as well as a brainstorming session on the final day to discuss where the microbiome field is headed research-wise.”
The Gut Microbiota for Health publishing team is pleased to provide highlights from this prestigious event through interviews with some of the speakers:
Paul O’Toole, University College Cork, Ireland
Eric Brown, University of British Columbia, Canada
We also present an interview with Sansonetti himself.
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014. Find her on: Google • Twitter
Studies over the last decade have brought new hope that gut microbiome-targeted therapeutics might offer novel treatments for obesity. In this post, we ask whether dietary interventions, prebiotics, probiotics and medication that target the microbiome are useful for weight management.
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.